Characteristics and Clinical Outcomes of Critically Ill Cancer Patients Admitted to Korean Intensive Care Units
- Author(s)
- Jisook Park; Juhee Cho; Kyeongman Jeon; Soo Jin Na; Tae Sun Ha; Younsuck Koh; Gee Young Suh; Shin Ok Koh; Chae-Man Lim; Won-Il Choi; Young-Joo Lee; Seok Chan Kim; Gyu Rak Chon; Je Hyeong Kim; Jae Yeol Kim; Jaemin Lim; Sunghoon Park; Ho Cheol Kim; Jin Hwa Lee; Ji Hyun Lee
- Keimyung Author(s)
- Choi, Won Il
- Department
- Dept. of Internal Medicine (내과학)
- Journal Title
- Acute and Critical Care
- Issued Date
- 2018
- Volume
- 33
- Issue
- 3
- Keyword
- cancer; critical care; epidemiology; hematologic neoplasm; mortality
- Abstract
- Background:
The objective of this study was to investigate the characteristics and clinical outcomes of critically ill cancer patients admitted to intensive care units (ICUs) in Korea.
Methods:
This was a retrospective cohort study that analyzed prospective collected data from the Validation of Simplified Acute Physiology Score 3 (SAPS3) in Korean ICU (VSKI) study, which is a nationwide, multicenter, and prospective study that considered 5,063 patients from 22 ICUs in Korea over a period of 7 months. Among them, patients older than 18 years of age who were diagnosed with solid or hematologic malignancies prior to admission to the ICU were included in the present study.
Results:
During the study period, a total of 1,762 cancer patients were admitted to the ICUs and 833 of them were deemed eligible for analysis. Six hundred fifty-eight (79%) had solid tumors and 175 (21%) had hematologic malignancies, respectively. Respiratory problems (30.1%) was the most common reason leading to ICU admission. Patients with hematologic malignancies had higher Sequential Organ Failure Assessment (12 vs. 8, P<0.001) and SAPS3 (71 vs. 69, P<0.001) values and were more likely to be associated with chemotherapy, steroid therapy, and immunocompromised status versus patients with solid tumors. The use of inotropes/vasopressors, mechanical ventilation, and/or continuous renal replacement therapy was more frequently required in hematologic malignancy patients. Mortality rates in the ICU(41.7% vs. 24.6%, P<0.001) and hospital (53.1% vs. 38.6%, P=0.002) were higher in hematologic malignancy patients than in solid tumor patients.
Conclusions:
Cancer patients accounted for one-third of all patients admitted to the studied ICUs in Korea. Clinical characteristics were different according to the type of malignancy. Patients with hematologic malignancies had a worse prognosis than did patients with solid tumor.
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.